These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 23355910)
21. An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD). Lomonaco R; Chen J; Cusi K Ther Adv Endocrinol Metab; 2011 Oct; 2(5):211-25. PubMed ID: 23148186 [TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease. Pettinelli P; Obregón AM; Videla LA Nutr Hosp; 2011; 26(3):441-50. PubMed ID: 21892559 [TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways. Perumpail RB; Liu A; Wong RJ; Ahmed A; Harrison SA World J Hepatol; 2015 Oct; 7(22):2384-8. PubMed ID: 26464753 [TBL] [Abstract][Full Text] [Related]
24. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease. Liu X; Chen S; Zhang L Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319 [TBL] [Abstract][Full Text] [Related]